Amryt Pharma - New Distribution Agreement Signed Expanding Route to Market - Raglan Capital

Home
About Us
Selected Transactions
Fundraising and Financial Support
Raglan IPO Projects
- Raglan Pharmaceutical & Life Science Projects
- Raglan Natural Resources
News
Contact us

Search

Amryt Pharma – New Distribution Agreement Signed Expanding Route to Market

Home
Uncategorized
Amryt Pharma – New Distribution Agreement Signed Expanding Route to Market

Recent News

Open Orphan signs option to acquire CHIMagents
Open Orphan agrees option to buy CHIMagents
Connect: Is antibody testing really a passport to Covid freedom?
Open Orphan developing world first challenge study model for Covid-19 vaccines
Open Orphan develops first challenge study model to test Covid-19 vaccines
Open Orphan sees positive trial on mosquito-borne disesases

Amryt Pharma - New Distribution Agreement Signed Expanding Route to Market

10th January 2018

https://otp.investis.com/clients/uk/amryt_pharmaceuticals_dac1/rns/regulatory-story.aspx?cid=1375&newsid=964733

Prev
Next

Join us for our newsletters

Raglan Capital
18 Fitzwilliam Place, Dublin 2.
T: +353 1 6440007
E: info@raglancapital.ie

Contact us
Careers
Privacy Policy
Cookie policy (EU)

Join us for our newsletters

Raglan Capital
18 Fitzwilliam Place, Dublin 2.
T: +353 1 6440007
E: info@raglancapital.ie

Contact us
Careers
Privacy Policy
Cookie policy (EU)

© 2020 Raglan Capital. All rights reserved

Privacy Preference Center

Privacy Preferences